Skip to main content


RA flare rates unaffected by tapering strategy

Rheumatoid arthritis medication

Rheumatoid arthritis flare rates are similar regardless of which drug type is tapered first after achievement of disease control during conventional synthetic DMARD and tumor necrosis factor inhibitor combination therapy, research shows.

18-04-2019 | Rheumatology | News | Article

Statins may have some benefits in patients with RA

Findings from the TRACE RA trial suggest that atorvastatin has a favorable safety profile and may reduce low-density lipoprotein cholesterol levels in patients with rheumatoid arthritis.

16-04-2019 | Rheumatology | News | Article

Inflammatory arthritis may impact sexual function

Findings from a systematic review suggest that sexual dysfunction is common among both men and women with inflammatory arthritis, highlighting the importance of including sexual health in the routine management of rheumatic disease.

15-04-2019 | Rheumatology | News | Article

Calprotectin levels separate septic arthritis from other inflammatory arthritides

Levels of calprotectin in the synovial fluid can be used to discriminate patients with septic arthritis from those with pseudogout and rheumatoid arthritis, shows a report published in Rheumatology.

12-04-2019 | Rheumatology | News | Article

Infliximab withdrawal not recommended for AS patients in remission

The decision to discontinue infliximab in ankylosing spondylitis patients who have achieved sustained remission “should be taken with considerable caution,” say Spanish researchers who found that over half relapsed after the tumor necrosis factor inhibitor was withdrawn.

Twitter Icon Follow medwireNews

Click here
image credits